RT @EricTopol: @JAMAInternalMed @American_Heart @ACCinTouch @jsross119 Adding the 2 relevant @cochranecollab systematic reviews. There is n…
RT @EricTopol: @JAMAInternalMed @American_Heart @ACCinTouch @jsross119 Adding the 2 relevant @cochranecollab systematic reviews. There is n…
RT @EricTopol: @JAMAInternalMed @American_Heart @ACCinTouch @jsross119 Adding the 2 relevant @cochranecollab systematic reviews. There is n…
RT @EricTopol: @JAMAInternalMed @American_Heart @ACCinTouch @jsross119 Adding the 2 relevant @cochranecollab systematic reviews. There is n…
RT @EricTopol: @JAMAInternalMed @American_Heart @ACCinTouch @jsross119 Adding the 2 relevant @cochranecollab systematic reviews. There is n…
RT @EricTopol: @JAMAInternalMed @American_Heart @ACCinTouch @jsross119 Adding the 2 relevant @cochranecollab systematic reviews. There is n…
RT @EricTopol: @JAMAInternalMed @American_Heart @ACCinTouch @jsross119 Adding the 2 relevant @cochranecollab systematic reviews. There is n…
RT @EricTopol: @JAMAInternalMed @American_Heart @ACCinTouch @jsross119 Adding the 2 relevant @cochranecollab systematic reviews. There is n…
RT @EricTopol: @JAMAInternalMed @American_Heart @ACCinTouch @jsross119 Adding the 2 relevant @cochranecollab systematic reviews. There is n…
RT @EricTopol: @JAMAInternalMed @American_Heart @ACCinTouch @jsross119 Adding the 2 relevant @cochranecollab systematic reviews. There is n…
RT @HHakeam: قبل المضي قدما وتبني توصيات AHA الجديدة, إمنح نفسك فرصة للإطلاع على رؤى أخرى https://t.co/V1tkZLP1HY
RT @EricTopol: @JAMAInternalMed @American_Heart @ACCinTouch @jsross119 Adding the 2 relevant @cochranecollab systematic reviews. There is n…
RT @EricTopol: @JAMAInternalMed @American_Heart @ACCinTouch @jsross119 Adding the 2 relevant @cochranecollab systematic reviews. There is n…
RT @BITNavarra: Blood pressure targets for the treatment of people with hypertension and cardiovascular disease, https://t.co/JImUpUSgPL
Objetivos de presión arterial en pacientes con enfermedad cardiovascular. Cochrane. La evidencia actual es insuficiente para justificar la presión arterial más bajos (≤ 135/85 mmHg) en los pacientes con HTA y enfermedad cardiovascular establecida https://t
RT @Actual_clinica: Objetivos de presión arterial en pacientes con enfermedad cardiovascular Cochrane https://t.co/hwOoi8vknB
Objetivos de presión arterial en pacientes con enfermedad cardiovascular Cochrane https://t.co/hwOoi8vknB
RT @DeeMangin: Evidence doesn't support push to lower BP targets in pts with hypertension + CVD new @CochraneLibrary #restrainRx https://t.…
RT @CEBAMvzw: Insufficient evidence for lower blood pressure targets (≤ 135/85 mmHg) in ppl with hypertension and CV disease. https://t.co/…
Insufficient evidence for lower blood pressure targets (≤ 135/85 mmHg) in ppl with hypertension and CV disease. https://t.co/LfJhfp0tzb
RT @DeeMangin: Evidence doesn't support push to lower BP targets in pts with hypertension + CVD new @CochraneLibrary #restrainRx https://t.…
RT @DeeMangin: Evidence doesn't support push to lower BP targets in pts with hypertension + CVD new @CochraneLibrary #restrainRx https://t.…
RT @DeeMangin: Evidence doesn't support push to lower BP targets in pts with hypertension + CVD new @CochraneLibrary #restrainRx https://t.…
RT @DeeMangin: Evidence doesn't support push to lower BP targets in pts with hypertension + CVD new @CochraneLibrary #restrainRx https://t.…
RT @DeeMangin: Evidence doesn't support push to lower BP targets in pts with hypertension + CVD new @CochraneLibrary #restrainRx https://t.…
RT @DeeMangin: Evidence doesn't support push to lower BP targets in pts with hypertension + CVD new @CochraneLibrary #restrainRx https://t.…
RT @KFSHRC_Research: Blood pressure targets for the treatment of people with #hypertension and cardiovascular disease https://t.co/HUHdl1XE…
RT @KFSHRC_Research: Blood pressure targets for the treatment of people with #hypertension and cardiovascular disease https://t.co/HUHdl1XE…
RT @KFSHRC_Research: Blood pressure targets for the treatment of people with #hypertension and cardiovascular disease https://t.co/HUHdl1XE…
RT @KFSHRC_Research: Blood pressure targets for the treatment of people with #hypertension and cardiovascular disease https://t.co/HUHdl1XE…
Blood pressure targets for the treatment of people with #hypertension and cardiovascular disease https://t.co/HUHdl1XELm https://t.co/C1VJUmoN6w
RT @DeeMangin: Evidence doesn't support push to lower BP targets in pts with hypertension + CVD new @CochraneLibrary #restrainRx https://t.…
RT @DeeMangin: Evidence doesn't support push to lower BP targets in pts with hypertension + CVD new @CochraneLibrary #restrainRx https://t.…
RT @DeeMangin: Evidence doesn't support push to lower BP targets in pts with hypertension + CVD new @CochraneLibrary #restrainRx https://t.…
RT @DeeMangin: Evidence doesn't support push to lower BP targets in pts with hypertension + CVD new @CochraneLibrary #restrainRx https://t.…
RT @DeeMangin: Evidence doesn't support push to lower BP targets in pts with hypertension + CVD new @CochraneLibrary #restrainRx https://t.…
RT @DeeMangin: Evidence doesn't support push to lower BP targets in pts with hypertension + CVD new @CochraneLibrary #restrainRx https://t.…
RT @DeeMangin: Evidence doesn't support push to lower BP targets in pts with hypertension + CVD new @CochraneLibrary #restrainRx https://t.…
RT @DeeMangin: Evidence doesn't support push to lower BP targets in pts with hypertension + CVD new @CochraneLibrary #restrainRx https://t.…
Evidence doesn't support push to lower BP targets in pts with hypertension + CVD new @CochraneLibrary #restrainRx https://t.co/SqklHScyB4
RT @rincondesisifo: (Cochrane) Objetivos de PA en pac hipertensos con enfermedad CV https://t.co/zU9OQtI9Vg Enhorabuena @BITNavarra
RT @MariadelMarRodr: Tratamiento intensivo de HTA en pacientes con enfermedad cardiovascular? https://t.co/8xvOvJ7dsb
RT @rincondesisifo: (Cochrane) Objetivos de PA en pac hipertensos con enfermedad CV https://t.co/zU9OQtI9Vg Enhorabuena @BITNavarra
RT @rincondesisifo: (Cochrane) Objetivos de PA en pac hipertensos con enfermedad CV https://t.co/zU9OQtI9Vg Enhorabuena @BITNavarra
RT @rincondesisifo: (Cochrane) Objetivos de PA en pac hipertensos con enfermedad CV https://t.co/zU9OQtI9Vg Enhorabuena @BITNavarra
Tratamiento intensivo de HTA en pacientes con enfermedad cardiovascular? https://t.co/8xvOvJ7dsb
(Cochrane) Objetivos de PA en pac hipertensos con enfermedad CV https://t.co/zU9OQtI9Vg Enhorabuena @BITNavarra
La evidencia no justifica bajar la TA a ≤ 135/85 en personas con HTA y enf. cardiovascular https://t.co/poJNTFpbbV https://t.co/u42vyMujby
RT @BITNavarra: Blood pressure targets for the treatment of people with hypertension and cardiovascular disease, https://t.co/JImUpUSgPL
Blood pressure targets for the treatment of people with hypertension and cardiovascular disease https://t.co/nRx6IxCKYX
RT @sanoysalvoblog: (Cochrane) La evidencia no justifica bajar la TA a ≤ 135/85 en personas con HTA y enfermedad cardiovascular https://t.c…
RT @martinezvelilla: Blood pressure targets for the treatment of people with hypertensi... https://t.co/NHGBcNEkdQ
RT @sanoysalvoblog: (Cochrane) La evidencia no justifica bajar la TA a ≤ 135/85 en personas con HTA y enfermedad cardiovascular https://t.c…
RT @BITNavarra: Blood pressure targets for the treatment of people with hypertension and cardiovascular disease, https://t.co/JImUpUSgPL
RT @sanoysalvoblog: (Cochrane) La evidencia no justifica bajar la TA a ≤ 135/85 en personas con HTA y enfermedad cardiovascular https://t.c…
RT @BITNavarra: Blood pressure targets for the treatment of people with hypertension and cardiovascular disease, https://t.co/JImUpUSgPL
RT @BITNavarra: Blood pressure targets for the treatment of people with hypertension and cardiovascular disease, https://t.co/JImUpUSgPL
RT @sanoysalvoblog: (Cochrane) La evidencia no justifica bajar la TA a ≤ 135/85 en personas con HTA y enfermedad cardiovascular https://t.c…
RT @sanoysalvoblog: (Cochrane) La evidencia no justifica bajar la TA a ≤ 135/85 en personas con HTA y enfermedad cardiovascular https://t.c…
RT @BITNavarra: Blood pressure targets for the treatment of people with hypertension and cardiovascular disease, https://t.co/JImUpUSgPL
RT @DTB_Navarre: Blood pressure targets for the treatment of people with hypertension and cardiovascular disease, https://t.co/ODqRaJpPvX
RT @BITNavarra: Blood pressure targets for the treatment of people with hypertension and cardiovascular disease, https://t.co/JImUpUSgPL
RT @sanoysalvoblog: (Cochrane) La evidencia no justifica bajar la TA a ≤ 135/85 en personas con HTA y enfermedad cardiovascular https://t.c…
RT @sanoysalvoblog: (Cochrane) La evidencia no justifica bajar la TA a ≤ 135/85 en personas con HTA y enfermedad cardiovascular https://t.c…
RT @sanoysalvoblog: (Cochrane) La evidencia no justifica bajar la TA a ≤ 135/85 en personas con HTA y enfermedad cardiovascular https://t.c…
RT @BITNavarra: Blood pressure targets for the treatment of people with hypertension and cardiovascular disease, https://t.co/JImUpUSgPL
RT @sanoysalvoblog: (Cochrane) La evidencia no justifica bajar la TA a ≤ 135/85 en personas con HTA y enfermedad cardiovascular https://t.c…
Revision GRADE sobre cifras objetivo de HTA https://t.co/dMFYH0buUa
RT @DTB_Navarre: Blood pressure targets for the treatment of people with hypertension and cardiovascular disease, https://t.co/ODqRaJpPvX
RT @sanoysalvoblog: (Cochrane) La evidencia no justifica bajar la TA a ≤ 135/85 en personas con HTA y enfermedad cardiovascular https://t.c…
RT @sanoysalvoblog: (Cochrane) La evidencia no justifica bajar la TA a ≤ 135/85 en personas con HTA y enfermedad cardiovascular https://t.c…
RT @sanoysalvoblog: (Cochrane) La evidencia no justifica bajar la TA a ≤ 135/85 en personas con HTA y enfermedad cardiovascular https://t.c…
RT @sanoysalvoblog: (Cochrane) La evidencia no justifica bajar la TA a ≤ 135/85 en personas con HTA y enfermedad cardiovascular https://t.c…
RT @sanoysalvoblog: (Cochrane) La evidencia no justifica bajar la TA a ≤ 135/85 en personas con HTA y enfermedad cardiovascular https://t.c…
RT @sanoysalvoblog: (Cochrane) La evidencia no justifica bajar la TA a ≤ 135/85 en personas con HTA y enfermedad cardiovascular https://t.c…
RT @sanoysalvoblog: (Cochrane) La evidencia no justifica bajar la TA a ≤ 135/85 en personas con HTA y enfermedad cardiovascular https://t.c…
RT @BITNavarra: Blood pressure targets for the treatment of people with hypertension and cardiovascular disease, https://t.co/JImUpUSgPL
RT @DTB_Navarre: Blood pressure targets for the treatment of people with hypertension and cardiovascular disease, https://t.co/ODqRaJpPvX
RT @sanoysalvoblog: (Cochrane) La evidencia no justifica bajar la TA a ≤ 135/85 en personas con HTA y enfermedad cardiovascular https://t.c…
RT @sanoysalvoblog: (Cochrane) La evidencia no justifica bajar la TA a ≤ 135/85 en personas con HTA y enfermedad cardiovascular https://t.c…
RT @sanoysalvoblog: (Cochrane) La evidencia no justifica bajar la TA a ≤ 135/85 en personas con HTA y enfermedad cardiovascular https://t.c…
RT @sanoysalvoblog: (Cochrane) La evidencia no justifica bajar la TA a ≤ 135/85 en personas con HTA y enfermedad cardiovascular https://t.c…
RT @sanoysalvoblog: (Cochrane) La evidencia no justifica bajar la TA a ≤ 135/85 en personas con HTA y enfermedad cardiovascular https://t.c…
RT @sanoysalvoblog: (Cochrane) La evidencia no justifica bajar la TA a ≤ 135/85 en personas con HTA y enfermedad cardiovascular https://t.c…
RT @sanoysalvoblog: (Cochrane) La evidencia no justifica bajar la TA a ≤ 135/85 en personas con HTA y enfermedad cardiovascular https://t.c…
RT @sanoysalvoblog: (Cochrane) La evidencia no justifica bajar la TA a ≤ 135/85 en personas con HTA y enfermedad cardiovascular https://t.c…
Revisione Cochrane che confronta 2 diversi target pressori in pz ipertesi in prevenzione secondaria https://t.co/GjFJgdvlLz
RT @sanoysalvoblog: (Cochrane) La evidencia no justifica bajar la TA a ≤ 135/85 en personas con HTA y enfermedad cardiovascular https://t.c…
RT @BITNavarra: Blood pressure targets for the treatment of people with hypertension and cardiovascular disease, https://t.co/JImUpUSgPL
RT @sanoysalvoblog: (Cochrane) La evidencia no justifica bajar la TA a ≤ 135/85 en personas con HTA y enfermedad cardiovascular https://t.c…
RT @sanoysalvoblog: (Cochrane) La evidencia no justifica bajar la TA a ≤ 135/85 en personas con HTA y enfermedad cardiovascular https://t.c…
RT @sanoysalvoblog: (Cochrane) La evidencia no justifica bajar la TA a ≤ 135/85 en personas con HTA y enfermedad cardiovascular https://t.c…
RT @sanoysalvoblog: (Cochrane) La evidencia no justifica bajar la TA a ≤ 135/85 en personas con HTA y enfermedad cardiovascular https://t.c…
RT @sanoysalvoblog: (Cochrane) La evidencia no justifica bajar la TA a ≤ 135/85 en personas con HTA y enfermedad cardiovascular https://t.c…
RT @sanoysalvoblog: (Cochrane) La evidencia no justifica bajar la TA a ≤ 135/85 en personas con HTA y enfermedad cardiovascular https://t.c…
RT @sanoysalvoblog: (Cochrane) La evidencia no justifica bajar la TA a ≤ 135/85 en personas con HTA y enfermedad cardiovascular https://t.c…
RT @sanoysalvoblog: (Cochrane) La evidencia no justifica bajar la TA a ≤ 135/85 en personas con HTA y enfermedad cardiovascular https://t.c…
RT @sanoysalvoblog: (Cochrane) La evidencia no justifica bajar la TA a ≤ 135/85 en personas con HTA y enfermedad cardiovascular https://t.c…
RT @sanoysalvoblog: (Cochrane) La evidencia no justifica bajar la TA a ≤ 135/85 en personas con HTA y enfermedad cardiovascular https://t.c…
(Cochrane) La evidencia no justifica bajar la TA a ≤ 135/85 en personas con HTA y enfermedad cardiovascular https://t.co/P8SxyF3sG6 #SegPac https://t.co/agNX8LxRNG